Structural Heart Disease Fellowship
The structural heart disease fellowship is a one year training program. To be eligible to apply, applicant must complete twelve months of dedicated interventional training and three years of general cardiology training.
The structural heart disease fellowship program provides clinical training in structural cardiac intervention and limited peripheral vascular intervention. Structural cardiac interventions include TAVR (150/yr), ASD/ PFO, TMVR, Mitral CLips, LAA Occlusion and valvuloplasty. The structural fellow will also experience the imaging processes and decision making associated with structural cardiac intervention. In addition to training in technical and procedural skills, fellows receive experience in pre- and post-procedural management, as well as in clinical decision-making. Trainees also participate in clinical trials in interventional/ structural cardiac disease.
One fellow is accepted into the program each year. The fellow will participate in cases performed at the University Hospital. The structural fellow will share STEMI call, journal clubs presentation and clinical conferences with the interventional fellows. In addition, the University of Utah is a designated center for Trans Aortic Valve Replacement (TAVR), and the program is also involved in structural cardiac intervention trials, including Evolut- Medtronic low risk TAVR trial, Portico TAVR trials, ASD Closure (ASSURED Trial) and Reduce- LAP HF trials under direct supervision.